The DNA damage response: The omics era and its impact

DNA Repair

Volumn 19, Issue , 2014, Pages 214-220

  Derks, Kasper W J ^a   Hoeijmakers, Jan H J ^a   Pothof, Joris ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

DNA damage response; Genomics; Next generation sequencing; Proteomics; Transcriptomics

Indexed keywords

ARTICLE; CLINICAL RESEARCH; DNA DAMAGE; DNA DAMAGE RESPONSE; GENOMICS; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEOMICS; TRANSCRIPTOMICS; AGING; GENETICS; HIGH THROUGHPUT SEQUENCING; NEOPLASM; PATHOLOGY; PROCEDURES; SIGNAL TRANSDUCTION;

AGING; DNA DAMAGE; GENOMICS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; NEOPLASMS; PROTEOMICS; SIGNAL TRANSDUCTION;

EID: 84902081860     PISSN: 15687864     EISSN: 15687856     Source Type: Journal    
DOI: 10.1016/j.dnarep.2014.03.008     Document Type: Article

References (87)

1. Hoeijmakers J.H. DNA damage, aging, and cancer. N. Engl. J. Med. 2009, 361(15):1475-1485.
2. Bartek J., Bartkova J., Lukas J. DNA damage signalling guards against activated oncogenes and tumour progression. Oncogene 2007, 26(56):7773-7779.
3. Curtin N.J. DNA repair dysregulation from cancer driver to therapeutic target. Nat. Rev. Cancer 2012, 12(12):801-817.
4. Bouwman P., Jonkers J. The effects of deregulated DNA damage signalling on cancer chemotherapy response and resistance. Nat. Rev. Cancer 2012, 12(9):587-598.
5. Jackson S.P., Bartek J. The DNA-damage response in human biology and disease. Nature 2009, 461(7267):1071-1078.
6. Harper J.W., Elledge S.J. The DNA damage response: ten years after. Mol. Cell 2007, 28(5):739-745.
7. Matsuoka S., Huang M., Elledge S.J. Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. Science 1998, 282(5395):1893-1897.
8. Bensimon A., Schmidt A., Ziv Y., Elkon R., Wang S.Y., Chen D.J., et al. ATM-dependent and -independent dynamics of the nuclear phosphoproteome after DNA damage. Sci. Signaling 2010, 3(151):rs3.
9. Bennetzen M.V., Larsen D.H., Bunkenborg J., Bartek J., Lukas J., Andersen J.S. Site-specific phosphorylation dynamics of the nuclear proteome during the DNA damage response. Mol. Cell. Proteomics: MCP 2010, 9(6):1314-1323.
10. Pines A., Kelstrup C.D., Vrouwe M.G., Puigvert J.C., Typas D., Misovic B., et al. Global phosphoproteome profiling reveals unanticipated networks responsive to cisplatin treatment of embryonic stem cells. Mol. Cell. Biol. 2011, 31(24):4964-4977.
11. Povlsen L.K., Beli P., Wagner S.A., Poulsen S.L., Sylvestersen K.B., Poulsen J.W., et al. Systems-wide analysis of ubiquitylation dynamics reveals a key role for PAF15 ubiquitylation in DNA-damage bypass. Nat. Cell Biol. 2012, 14(10):1089-1098.
12. Schwertman P., Lagarou A., Dekkers D.H., Raams A., van der Hoek A.C., Laffeber C., et al. UV-sensitive syndrome protein UVSSA recruits USP7 to regulate transcription-coupled repair. Nat. Genet. 2012, 44(5):598-602.
13. Galanty Y., Belotserkovskaya R., Coates J., Polo S., Miller K.M., Jackson S.P. Mammalian SUMO E3-ligases PIAS1 and PIAS4 promote responses to DNA double-strand breaks. Nature 2009, 462(7275):935-939.
14. Morris J.R. SUMO in the mammalian response to DNA damage. Biochem. Soc. Trans. 2010, 38(Pt 1):92-97.
15. Guenole A., Srivas R., Vreeken K., Wang Z.Z., Wang S., Krogan N.J., et al. Dissection of DNA damage responses using multiconditional genetic interaction maps. Mol. Cell 2013, 49(2):346-358.
16. Pines A., Vrouwe M.G., Marteijn J.A., Typas D., Luijsterburg M.S., Cansoy M., et al. PARP1 promotes nucleotide excision repair through DDB2 stabilization and recruitment of ALC1. J. Cell Biol. 2012, 199(2):235-249.
17. Beli P., Lukashchuk N., Wagner S.A., Weinert B.T., Olsen J.V., Baskcomb L., et al. Proteomic investigations reveal a role for RNA processing factor THRAP3 in the DNA damage response. Mol. Cell 2012, 46(2):212-225.
18. Kruse J.P., Gu W. Modes of p53 regulation. Cell 2009, 137(4):609-622.
19. Daub H. DNA damage response: multilevel proteomics gains momentum. Mol. Cell 2012, 46(2):113-114.
20. Walther T.C., Mann M. Mass spectrometry-based proteomics in cell biology. J. Cell Biol. 2010, 190(4):491-500.
21. Kruse J.J., Svensson J.P., Huigsloot M., Giphart-Gassler M., Schoonen W.G., Polman J.E., et al. A portrait of cisplatin-induced transcriptional changes in mouse embryonic stem cells reveals a dominant p53-like response. Mutat. Res. 2007, 617(1-2):58-70.
22. Garinis G.A., Mitchell J.R., Moorhouse M.J., Hanada K., de Waard H., Vandeputte D., et al. Transcriptome analysis reveals cyclobutane pyrimidine dimers as a major source of UV-induced DNA breaks. EMBO J. 2005, 24(22):3952-3962.
23. Garinis G.A., Uittenboogaard L.M., Stachelscheid H., Fousteri M., van Ijcken W., Breit T.M., et al. Persistent transcription-blocking DNA lesions trigger somatic growth attenuation associated with longevity. Nat. Cell Biol. 2009, 11(5):604-615.
24. Niedernhofer L.J., Garinis G.A., Raams A., Lalai A.S., Robinson A.R., Appeldoorn E., et al. A new progeroid syndrome reveals that genotoxic stress suppresses the somatotroph axis. Nature 2006, 444(7122):1038-1043.
25. Schumacher B., van der Pluijm I., Moorhouse M.J., Kosteas T., Robinson A.R., Suh Y., et al. Delayed and accelerated aging share common longevity assurance mechanisms. PLoS Genet. 2008, 4(8):e1000161.
26. Dolle M.E., Kuiper R.V., Roodbergen M., Robinson J., de Vlugt S., Wijnhoven S.W., et al. Broad segmental progeroid changes in short-lived Ercc1(-/Delta7) mice. Pathobiol. Aging Age-Relat. Dis. 2011, 1.
27. Wilusz J.E., Sunwoo H., Spector D.L. Long noncoding RNAs: functional surprises from the RNA world. Genes Dev. 2009, 23(13):1494-1504.
28. Djebali S., Davis C.A., Merkel A., Dobin A., Lassmann T., Mortazavi A., et al. Landscape of transcription in human cells. Nature 2012, 489(7414):101-108.
29. Guo H., Ingolia N.T., Weissman J.S., Bartel D.P. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 2010, 466(7308):835-840.
30. Lu J., Getz G., Miska E.A., Alvarez-Saavedra E., Lamb J., Peck D., et al. MicroRNA expression profiles classify human cancers. Nature 2005, 435(7043):834-838.
31. Pothof J., Verkaik N.S., van I.W., Wiemer E.A., Ta V.T., van der Horst G.T., et al. MicroRNA-mediated gene silencing modulates the UV-induced DNA-damage response. EMBO J. 2009, 28(14):2090-2099.
32. Girardi C., De Pitta C., Casara S., Sales G., Lanfranchi G., Celotti L., et al. Analysis of miRNA and mRNA expression profiles highlights alterations in ionizing radiation response of human lymphocytes under modeled microgravity. PLoS One 2012, 7(2):e31293.
33. Di Francesco A., De Pitta C., Moret F., Barbieri V., Celotti L., Mognato M. The DNA-damage response to gamma-radiation is affected by miR-27a in A549 cells. Int. J. Mol. Sci. 2013, 14(9):17881-17896.
34. Neijenhuis S., Bajrami I., Miller R., Lord C.J., Ashworth A. Identification of miRNA modulators to PARP inhibitor response. DNA Repair 2013, 12(6):394-402.
35. Dolezalova D., Mraz M., Barta T., Plevova K., Vinarsky V., Holubcova Z., et al. MicroRNAs regulate p21(Waf1/Cip1) protein expression and the DNA damage response in human embryonic stem cells. Stem Cells 2012, 30(7):1362-1372.
36. van Jaarsveld M.T., Helleman J., Boersma A.W., van Kuijk P.F., van Ijcken W.F., Despierre E., et al. miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells. Oncogene 2013, 32(36):4284-4293.
37. Pothof J., Verkaik N.S., Hoeijmakers J.H., van Gent D.C. MicroRNA responses and stress granule formation modulate the DNA damage response. Cell Cycle 2009, 8(21):3462-3468.
38. Zhang X., Wan G., Berger F.G., He X., Lu X. The ATM kinase induces microRNA biogenesis in the DNA damage response. Mol. Cell 2011, 41(4):371-383.
39. Wouters M.D., van Gent D.C., Hoeijmakers J.H., Pothof J. MicroRNAs, the DNA damage response and cancer. Mutat. Res. 2011, 717(1-2):54-66.
40. van Jaarsveld M.T., Wouters M.D., Boersma A.W., Smid M., van Ijcken W.F., Mathijssen R.H., et al. DNA damage responsive microRNAs misexpressed in human cancer modulate therapy sensitivity. Mol. Oncol. 2013, (ahead of print). 10.1016/j.molonc.2013.12.011.
41. Esteller M. Non-coding RNAs in human disease. Nat. Rev. Genet. 2011, 12(12):861-874.
42. Guttman M., Rinn J.L. Modular regulatory principles of large non-coding RNAs. Nature 2012, 482(7385):339-346.
43. Jensen T.H., Jacquier A., Libri D. Dealing with pervasive transcription. Mol. Cell 2013, 52(4):473-484.
44. Mattick J.S. The genetic signatures of noncoding RNAs. PLoS Genet. 2009, 5(4):e1000459.
45. Mattick J.S. Long noncoding RNAs in cell and developmental biology. Semin. Cell Dev. Biol. 2011, 22(4):327.
46. Ulitsky I., Bartel D.P. lincRNAs: genomics, evolution, and mechanisms. Cell 2013, 154(1):26-46.
47. Zhao J., Ohsumi T.K., Kung J.T., Ogawa Y., Grau D.J., Sarma K., et al. Genome-wide identification of polycomb-associated RNAs by RIP-seq. Mol. Cell 2010, 40(6):939-953.
48. Carninci P. Is sequencing enlightenment ending the dark age of the transcriptome?. Nat. Methods 2009, 6(10):711-713.
49. Maher C.A., Palanisamy N., Brenner J.C., Cao X., Kalyana-Sundaram S., Luo S., et al. Chimeric transcript discovery by paired-end transcriptome sequencing. Proc. Nat. Acad. Sci. U.S.A. 2009, 106(30):12353-12358.
50. Mitelman F., Johansson B., Mertens F. The impact of translocations and gene fusions on cancer causation. Nat. Rev. Cancer 2007, 7(4):233-245.
51. Maher C.A., Kumar-Sinha C., Cao X., Kalyana-Sundaram S., Han B., Jing X., et al. Transcriptome sequencing to detect gene fusions in cancer. Nature 2009, 458(7234):97-101.
52. Zhao Q., Caballero O.L., Levy S., Stevenson B.J., Iseli C., de Souza S.J., et al. Transcriptome-guided characterization of genomic rearrangements in a breast cancer cell line. Proc. Nat. Acad. Sci. U.S.A. 2009, 106(6):1886-1891.
53. Berger M.F., Levin J.Z., Vijayendran K., Sivachenko A., Adiconis X., Maguire J., et al. Integrative analysis of the melanoma transcriptome. Genome Res. 2010, 20(4):413-427.
54. Ameres S.L., Zamore P.D. Diversifying microRNA sequence and function. Nat. Rev. Mol. Cell Biol. 2013, 14(8):475-488.
55. Neilsen C.T., Goodall G.J., Bracken C.P. IsomiRs-the overlooked repertoire in the dynamic microRNAome. Trends Genet. 2012, 28(11):544-549.
56. Pelechano V., Wei W., Steinmetz L.M. Extensive transcriptional heterogeneity revealed by isoform profiling. Nature 2013, 497(7447):127-131.
57. Churchman L.S., Weissman J.S. Nascent transcript sequencing visualizes transcription at nucleotide resolution. Nature 2011, 469(7330):368-373.
58. Core L.J., Waterfall J.J., Lis J.T. Nascent RNA sequencing reveals widespread pausing and divergent initiation at human promoters. Science 2008, 322(5909):1845-1848.
59. Kanematsu S., Tanimoto K., Suzuki Y., Sugano S. Screening for possible miRNA-mRNA associations in a colon cancer cell line. Gene 2014, 533(2):520-531.
60. Li A., Wei G., Wang Y., Zhou Y., Zhang X.E., Bi L., et al. Identification of intermediate-size non-coding RNAs involved in the UV-induced DNA damage response in C. elegans. PLoS One 2012, 7(11):e48066.
61. Liu Q., Ullery J., Zhu J., Liebler D.C., Marnett L.J., Zhang B. RNA-seq data analysis at the gene and CDS levels provides a comprehensive view of transcriptome responses induced by 4-hydroxynonenal. Mol. Biosyst. 2013, 9(12):3036-3046.
62. Kenzelmann Broz D., Spano Mello S., Bieging K.T., Jiang D., Dusek R.L., Brady C.A., et al. Global genomic profiling reveals an extensive p53-regulated autophagy program contributing to key p53 responses. Genes Dev. 2013, 27(9):1016-1031.
63. Li G., Qiu Y., Su Z., Ren S., Liu C., Tian Y., et al. Genome-wide analyses of radioresistance-associated miRNA expression profile in nasopharyngeal carcinoma using next generation deep sequencing. PLoS One 2013, 8(12):e84486.
64. Hart M., Nolte E., Wach S., Szczyrba J., Taubert H., Rau T., et al. Comparative microRNA profiling of prostate carcinomas with increasing tumor stage by deep-sequencing. Mol. Cancer Res.: MCR 2013, 12:250-263.
65. Huarte M., Guttman M., Feldser D., Garber M., Koziol M.J., Kenzelmann-Broz D., et al. A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell 2010, 142(3):409-419.
66. Liu Q., Huang J., Zhou N., Zhang Z., Zhang A., Lu Z., et al. LncRNA loc285194 is a p53-regulated tumor suppressor. Nucleic Acids Res. 2013, 41(9):4976-4987.
67. Zhang A., Zhou N., Huang J., Liu Q., Fukuda K., Ma D., et al. The human long non-coding RNA-RoR is a p53 repressor in response to DNA damage. Cell Res. 2013, 23(3):340-350.
68. Marin-Bejar O., Marchese F.P., Athie A., Sanchez Y., Gonzalez J., Segura V., et al. Pint lincRNA connects the p53 pathway with epigenetic silencing by the polycomb repressive complex 2. Genome Biol. 2013, 14(9):R104.
69. Paulsen M.T., Veloso A., Prasad J., Bedi K., Ljungman E.A., Tsan Y.C., et al. Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response. Proc. Nat. Acad. Sci. U.S.A. 2013, 110(6):2240-2245.
70. Francia S., Michelini F., Saxena A., Tang D., de Hoon M., Anelli V., et al. Site-specific DICER and DROSHA RNA products control the DNA-damage response. Nature 2012, 488(7410):231-235.
71. Ng S.B., Turner E.H., Robertson P.D., Flygare S.D., Bigham A.W., Lee C., et al. Targeted capture and massively parallel sequencing of 12 human exomes. Nature 2009, 461(7261):272-276.
72. Stolk L., Perry J.R., Chasman D.I., He C., Mangino M., Sulem P., et al. Meta-analyses identify 13 loci associated with age at menopause and highlight DNA repair and immune pathways. Nat. Genet. 2012, 44(3):260-268.
73. Zhou W., Otto E.A., Cluckey A., Airik R., Hurd T.W., Chaki M., et al. FAN1 mutations cause karyomegalic interstitial nephritis, linking chronic kidney failure to defective DNA damage repair. Nat. Genet. 2012, 44(8):910-915.
74. Nakazawa Y., Sasaki K., Mitsutake N., Matsuse M., Shimada M., Nardo T., et al. Mutations in UVSSA cause UV-sensitive syndrome and impair RNA polymerase IIo processing in transcription-coupled nucleotide-excision repair. Nat. Genet. 2012, 44(5):586-592.
75. Gundry M., Li W., Maqbool S.B., Vijg J. Direct, genome-wide assessment of DNA mutations in single cells. Nucleic Acids Res. 2012, 40(5):2032-2040.
76. Falconer E., Hills M., Naumann U., Poon S.S., Chavez E.A., Sanders A.D., et al. DNA template strand sequencing of single-cells maps genomic rearrangements at high resolution. Nat. Methods 2012, 9(11):1107-1112.
77. de Wit E., de Laat W. A decade of 3C technologies: insights into nuclear organization. Genes Dev. 2012, 26(1):11-24.
78. Hakim O., Resch W., Yamane A., Klein I., Kieffer-Kwon K.R., Jankovic M., et al. DNA damage defines sites of recurrent chromosomal translocations in B lymphocytes. Nature 2012, 484(7392):69-74.
79. Melo C.A., Drost J., Wijchers P.J., van de Werken H., de Wit E., Oude Vrielink J.A., et al. eRNAs are required for p53-dependent enhancer activity and gene transcription. Mol. Cell 2013, 49(3):524-535.
80. Iacovoni J.S., Caron P., Lassadi I., Nicolas E., Massip L., Trouche D., et al. High-resolution profiling of gammaH2AX around DNA double strand breaks in the mammalian genome. EMBO J. 2010, 29(8):1446-1457.
81. Massip L., Caron P., Iacovoni J.S., Trouche D., Legube G. Deciphering the chromatin landscape induced around DNA double strand breaks. Cell Cycle 2010, 9(15):2963-2972.
82. Akdemir K.C., Jain A.K., Allton K., Aronow B., Xu X., Cooney A.J., et al. Genome-wide profiling reveals stimulus-specific functions of p53 during differentiation and DNA damage of human embryonic stem cells. Nucleic Acids Res. 2013.
83. Zhou Z.X., Zhang M.J., Peng X., Takayama Y., Xu X.Y., Huang L.Z., et al. Mapping genomic hotspots of DNA damage by a single-strand-DNA-compatible and strand-specific ChIP-seq method. Genome Res. 2013, 23(4):705-715.
84. Crosetto N., Mitra A., Silva M.J., Bienko M., Dojer N., Wang Q., et al. Nucleotide-resolution DNA double-strand break mapping by next-generation sequencing. Nat. Methods 2013, 10(4):361-365.
85. Park P.J. ChIP-seq: advantages and challenges of a maturing technology. Nat. Rev. Genet. 2009, 10(10):669-680.
86. Stockholm D., Benchaouir R., Picot J., Rameau P., Neildez T.M., Landini G., et al. The origin of phenotypic heterogeneity in a clonal cell population in vitro. PLoS One 2007, 2(4):e394.
87. Shapiro E., Biezuner T., Linnarsson S. Single-cell sequencing-based technologies will revolutionize whole-organism science. Nat. Rev. Genet. 2013, 14(9):618-630.